Opdivo & Death

12.9%

of users reported Death

55.2%

also reported Severe reaction

64.2%

are men

Severe reaction

55.2%

Death

44.2%

Hospitalization

0.5%

Life-threatening condition

<0.1%

Opdivo: general information

10 - 19 years

0.1%

20 - 29 years

1.0%

30 - 39 years

2.2%

40 - 49 years

6.7%

50 - 59 years

17.1%

60 - 69 years

32.4%

70 - 79 years

31.3%

80 - 89 years

8.7%

90 - 99 years

0.5%